Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.44 |
| ▸ | P2RY12 | Q9H244 | 2/20 | 0.43 |
| ▸ | ABL1 | P00519 | 3/20 | 0.42 |
| ▸ | RIN1 | Q13671 | 3/20 | 0.42 |
| ▸ | BMPR1B | O00238 | 1/20 | 0.42 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.42 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.41 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.41 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25764318 | 0.91 | BMPR1B (0.44) | PRMT6P2RY12BMPR1BADORA1 | |
| SCHEMBL19146448 | 0.89 | CYP1A2 (0.48) | PRMT6P2RY12ABL1RIN1 | |
| SCHEMBL19953997 | 0.83 | PRMT6 (0.43) | PRMT6P2RY12ABL1RIN1 | |
| SCHEMBL23379924 | 0.82 | BMPR1B (0.41) | PRMT6P2RY12BMPR1BADORA1ADORA3 | |
| SCHEMBL19343832 | 0.82 | ABL1 (0.56) | ABL1RIN1 | |
| SCHEMBL25004 | 0.82 | ABL1 (0.56) | ABL1RIN1 | |
| SCHEMBL9342988 | 0.81 | SLC29A1 (0.49) | PRMT6P2RY12ADORA3 | |
| SCHEMBL9342970 | 0.81 | SLC29A1 (0.49) | PRMT6P2RY12ADORA3 | |
| SCHEMBL14999606 | 0.79 | P2RY12 (0.41) | PRMT6P2RY12 | |
| SCHEMBL19146385 | 0.79 | CYP1A2 (0.44) | PRMT6P2RY12ABL1RIN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120296087-A1 | MORPHOLINO-BASED ANTISENSE AGENT | INDIAN ASSOCIATION FOR THE CULTIVATION OF SCIENCE (IN) | 2012-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120296087-A1 | MORPHOLINO-BASED ANTISENSE AGENT | MYOF, OSBP2, SLCO2B1 | PRMT6 4002/4885P2RY12 554/4885ABL1 4099/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.